drugset / Trial / NCT00129675
Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty
Phase 2
Completed
169 enrolled
Institute for Neurodegenerative Disorders
Molecular NeuroImaging · collab
NaSingle-groupSingle-blindDiagnostic
Summary
The overall goal of this study is to evaluate the use of dopamine transporter (DAT) imaging as a diagnostic tool in subjects with early parkinsonian symptoms, in whom Parkinson's disease (PD) or parkinsonian syndrome (PS) is suspected, but the diagnosis remains unclear from a clinical standpoint.
Timeline
- Start
- 2003-02
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [123I]ß CIT | Unknown | — | Other |